These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 36916178)
21. Verification of surface contamination of Japanese cyclophosphamide vials and an example of exposure by handling. Hama K; Fukushima K; Hirabatake M; Hashida T; Kataoka K J Oncol Pharm Pract; 2012 Jun; 18(2):201-6. PubMed ID: 21947739 [TBL] [Abstract][Full Text] [Related]
23. Application and assessment of a regular environmental monitoring of the antineoplastic drug contamination level in pharmacies - the MEWIP project. Kiffmeyer TK; Tuerk J; Hahn M; Stuetzer H; Hadtstein C; Heinemann A; Eickmann U Ann Occup Hyg; 2013 May; 57(4):444-55. PubMed ID: 23125441 [TBL] [Abstract][Full Text] [Related]
24. Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device. Sessink PJ; Connor TH; Jorgenson JA; Tyler TG J Oncol Pharm Pract; 2011 Mar; 17(1):39-48. PubMed ID: 20156932 [TBL] [Abstract][Full Text] [Related]
25. Environmental contamination with cytotoxic drugs in healthcare using positive air pressure isolators. Crauste-Manciet S; Sessink PJ; Ferrari S; Jomier JY; Brossard D Ann Occup Hyg; 2005 Oct; 49(7):619-28. PubMed ID: 16126757 [TBL] [Abstract][Full Text] [Related]
26. Occupational exposure to antineoplastic agents at several departments in a hospital. Environmental contamination and excretion of cyclophosphamide and ifosfamide in urine of exposed workers. Sessink PJ; Boer KA; Scheefhals AP; Anzion RB; Bos RP Int Arch Occup Environ Health; 1992; 64(2):105-12. PubMed ID: 1399019 [TBL] [Abstract][Full Text] [Related]
27. [Antiblastic drug exposure: statistical analysis of the data coming from environmental monitoring of a site devoted to drug production]. Miraglia N; Castiglia L; Muselli A; Astarita S; Acampora A; Sannolo N G Ital Med Lav Ergon; 2007; 29(3 Suppl):739-40. PubMed ID: 18409934 [TBL] [Abstract][Full Text] [Related]
28. Proposals of guidance values for surface contamination by antineoplastic drugs based on long term monitoring in Czech and Slovak hospitals and pharmacies. Bláhová L; Bláha L; Doležalová L; Kuta J; Hojdarová T Front Public Health; 2023; 11():1235496. PubMed ID: 37780438 [TBL] [Abstract][Full Text] [Related]
29. Cytotoxic drug contamination on the outside of vials delivered to a hospital pharmacy. Mason HJ; Morton J; Garfitt SJ; Iqbal S; Jones K Ann Occup Hyg; 2003 Nov; 47(8):681-5. PubMed ID: 14602675 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of occupational exposure to antiblastic drugs in an Italian hospital oncological department. Castiglia L; Miraglia N; Pieri M; Simonelli A; Basilicata P; Genovese G; Guadagni R; Acampora A; Sannolo N; Scafarto MV J Occup Health; 2008; 50(1):48-56. PubMed ID: 18285644 [TBL] [Abstract][Full Text] [Related]
31. Canadian monitoring program of the surface contamination with 11 antineoplastic drugs in 122 centers. Delafoy C; Roussy C; Hudon AF; Cirtiu CM; Caron N; Bussières JF; Tanguay C J Oncol Pharm Pract; 2023 Mar; 29(2):338-347. PubMed ID: 35018847 [TBL] [Abstract][Full Text] [Related]
32. The application of novel field measurement and field evaluation protocols for assessing health care workers' exposure risk to antineoplastic drugs. Astrakianakis G; Jeronimo M; Griffiths A; Colombo M; Kramer D; Demers PA; Hon CY J Occup Environ Hyg; 2020 Sep; 17(9):373-382. PubMed ID: 32615872 [TBL] [Abstract][Full Text] [Related]
33. UPLC-MS/MS method for simultaneous determination of cyclophosphamide, docetaxel, doxorubicin and 5-fluorouracil in surface samples. da Silva CB; Julio IP; Donadel GE; Martins I J Pharmacol Toxicol Methods; 2016; 82():68-73. PubMed ID: 27521053 [TBL] [Abstract][Full Text] [Related]
34. Occupational exposure to antineoplastic drugs: what about hospital sanitation personnel? Labrèche F; Ouellet C; Roberge B; Caron NJ; Yennek A; Bussières JF Int Arch Occup Environ Health; 2021 Nov; 94(8):1877-1888. PubMed ID: 34410477 [TBL] [Abstract][Full Text] [Related]
35. Surface contamination of chemotherapy drug vials and evaluation of new vial-cleaning techniques: results of three studies. Connor TH; Sessink PJ; Harrison BR; Pretty JR; Peters BG; Alfaro RM; Bilos A; Beckmann G; Bing MR; Anderson LM; Dechristoforo R Am J Health Syst Pharm; 2005 Mar; 62(5):475-84. PubMed ID: 15745910 [TBL] [Abstract][Full Text] [Related]
36. Surface contamination of the outer and blister packages of oral anticancer drugs: A multicenter study. Nomura H; Katakura N; Morita T; Sano Y; Usui H; Hiura S; Nakakuni M; Otsuka M; Akiyama E; Endo K J Oncol Pharm Pract; 2020 Jan; 26(1):141-145. PubMed ID: 31132937 [TBL] [Abstract][Full Text] [Related]
37. Pilot assessment of the antineoplastic drug contamination levels in British Columbian hospitals pre- and post-cleaning. Chu WC; Hon CY; Danyluk Q; Chua PP; Astrakianakis G J Oncol Pharm Pract; 2012 Mar; 18(1):46-51. PubMed ID: 21737485 [TBL] [Abstract][Full Text] [Related]
38. Cross-sectional evaluation of surface contamination with 9 antineoplastic drugs in 93 Canadian healthcare centers: 2019 results. Palamini M; Gagné S; Caron N; Bussières JF J Oncol Pharm Pract; 2020 Dec; 26(8):1921-1930. PubMed ID: 32114883 [TBL] [Abstract][Full Text] [Related]
39. Simultaneous determination of gemcitabine, taxol, cyclophosphamide and ifosfamide in wipe samples by high-performance liquid chromatography/tandem mass spectrometry: protocol of validation and uncertainty of measurement. Sottani C; Turci R; Schierl R; Gaggeri R; Barbieri A; Violante FS; Minoia C Rapid Commun Mass Spectrom; 2007; 21(7):1289-96. PubMed ID: 17340557 [TBL] [Abstract][Full Text] [Related]
40. The efficiency of antineoplastic drug contamination removal by widely used disinfectants-laboratory and hospital studies. Bláhová L; Kuta J; Doležalová L; Kozáková Š; Krovová T; Bláha L Int Arch Occup Environ Health; 2021 Oct; 94(7):1687-1702. PubMed ID: 33738516 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]